Preparation and Evaluation of Heat-sensitive Melting Gel

H. Endo, Yoshiteru Watanabe, M. Matsumoto, Shoichi Shirotake
{"title":"Preparation and Evaluation of Heat-sensitive Melting Gel","authors":"H. Endo, Yoshiteru Watanabe, M. Matsumoto, Shoichi Shirotake","doi":"10.5649/JJPHCS1975.26.250","DOIUrl":null,"url":null,"abstract":"The aim of the present study was to prepare a heat-sensitive melting gel using κ-carrageenan and gelatin as the gelation agents. The two agents have similar melting points (40-50°C for κ-carrageenan and 20-30°C for gelatin). When mixed together, they have a coexisting grid structure, which is favorable for the preparation of a gel with a melting temperature close to the human body temperature. Gel preparation showed a clearly different melting behavior from that of many other compounds and began to soften significantly below its melting temperature.κ-carrageenan at 0.5% may thus be the preferred concentration because preparations having a melting temperature just below the human body temperature are easy to chew, with a rapidly decreasing viscosity. We studied the plasma concentrations of acetaminophen as a function of time after the oral administration of a bulk powder or gel preparation of acetaminophen to rabbits after overnight fasting. A comparison of the AUC for both oral and intravenous administration indicated the bioavailability of acetaminophen gel to be about 90%. The heat-sensitive acetaminophen melting gel prepared using κ-carrageenan and gelatin thus shows promise for clinical use because of its favorable physicochemical and pharmaceutical characteristics.","PeriodicalId":14621,"journal":{"name":"Japanese Journal of Hospital Pharmacy","volume":"9 1","pages":"250-258"},"PeriodicalIF":0.0000,"publicationDate":"2000-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5649/JJPHCS1975.26.250","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

The aim of the present study was to prepare a heat-sensitive melting gel using κ-carrageenan and gelatin as the gelation agents. The two agents have similar melting points (40-50°C for κ-carrageenan and 20-30°C for gelatin). When mixed together, they have a coexisting grid structure, which is favorable for the preparation of a gel with a melting temperature close to the human body temperature. Gel preparation showed a clearly different melting behavior from that of many other compounds and began to soften significantly below its melting temperature.κ-carrageenan at 0.5% may thus be the preferred concentration because preparations having a melting temperature just below the human body temperature are easy to chew, with a rapidly decreasing viscosity. We studied the plasma concentrations of acetaminophen as a function of time after the oral administration of a bulk powder or gel preparation of acetaminophen to rabbits after overnight fasting. A comparison of the AUC for both oral and intravenous administration indicated the bioavailability of acetaminophen gel to be about 90%. The heat-sensitive acetaminophen melting gel prepared using κ-carrageenan and gelatin thus shows promise for clinical use because of its favorable physicochemical and pharmaceutical characteristics.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
热敏熔融凝胶的制备与评价
以κ-卡拉胶和明胶为胶凝剂,制备热敏性熔融凝胶。这两种试剂的熔点相似(κ-卡拉胶为40-50°C,明胶为20-30°C)。当它们混合在一起时,它们具有共存的网格结构,这有利于制备熔化温度接近人体温度的凝胶。凝胶制备表现出明显不同于许多其他化合物的熔化行为,并在其熔化温度以下开始明显软化。因此,0.5%的κ-卡拉胶可能是首选浓度,因为熔点略低于人体温度的制剂易于咀嚼,粘度迅速下降。我们研究了兔在禁食一夜后口服对乙酰氨基酚散装粉末或凝胶制剂后,对乙酰氨基酚血浆浓度随时间的变化。口服和静脉给药的AUC比较表明,对乙酰氨基酚凝胶的生物利用度约为90%。以κ-卡拉胶和明胶为原料制备的热敏性对乙酰氨基酚熔融凝胶具有良好的理化和药学特性,具有广阔的临床应用前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Assessment and Analysis of the Assessment Criteria for Meta-Analysis Articles:─ Management of Diabetes Pharmacotherapy Based on Meta-Analysis Articles ─ ベネコートBMI-40とBMI-60との苦味マスキング効果の比較 「創薬ボランティアのしおり」,「被験者管理票」の利用と治験コーディネーター業務 Hemodializability of Pimobendan and Its Active Metabolite, UD-CG 212, in Patients with Congestive Heart Failure Undergoing Hemodialysis An Investigation into the Current Management for Patients with Long-Term Withdrawal Periods from Drugs
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1